News Release

Pharmaceutical/Lobbyist retained

Date: 1999/03/19

International Wex Technologies(IWT/the Company) today announces that it has contracted for the services of BatAuTe Ltd.(BAT), a specialty lobbyist and consulting firm. BAT will set out the procedures and submissions for obtaining the IND(Investigational New Drug) and NDA(New Drug Application) for Tetrodin (HT) in the Peoples’ Republic of China.

BAT assists companies to organize and prepare the material necessary to receive a New Drug License in China. BAT has extensive experience in all the technical requirements, rules and coordination necessary to expedite the approval process in China. BAT will be responsible for all liaisons between the government licensing agency and International Wex Technologies Inc. The Company is confident this agreement will facilitate our new drug approval for Tetrodin(HT).

The full group of observers will record, document and report their findings to all interested parties .

Tetrodin (HT) is a patented non-narcotic withdrawal treatment for Heroin and all other opiates addictions.

For additional information on Tetrodin (HT), view the IWT website at http://www.wextech.ca or call Howard Milne at 604-683-8880 or 1-800-722-7549 .

Per: Donna Shum, Corporate Secretary